MRNA is expected to report earnings to rise 17.86% to -297 cents per share on July 31
Q2'25
Est.
$-2.97
Q1'25
Beat
by $0.66
Q4'24
Missed
by $0.18
Q3'24
Beat
by $1.95
Q2'24
Beat
by $0.02
The last earnings report on May 01 showed earnings per share of -251 cents, beating the estimate of -318 cents. With 2.76M shares outstanding, the current market capitalization sits at 9.38B.